Integral Ad Science (NASDAQ:IAS) Receives Equal Weight Rating from Morgan Stanley

Morgan Stanley reiterated their equal weight rating on shares of Integral Ad Science (NASDAQ:IAS) in a research note issued to investors on Tuesday morning, Marketbeat.com reports. They currently have a $12.00 price objective on the stock, down from their prior price objective of $18.00.

IAS has been the subject of several other reports. Bank of America started coverage on Integral Ad Science in a research note on Thursday, January 11th. They issued a buy rating and a $19.00 price objective for the company. BMO Capital Markets reduced their price objective on Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a research note on Wednesday, February 28th. Piper Sandler dropped their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an overweight rating for the company in a report on Wednesday, February 28th. Truist Financial cut their price target on Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research note on Wednesday, February 28th. Finally, Raymond James lowered Integral Ad Science from a strong-buy rating to an outperform rating and cut their price target for the stock from $20.00 to $16.00 in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, Integral Ad Science has an average rating of Moderate Buy and an average target price of $17.58.

Integral Ad Science Price Performance

Shares of IAS opened at $9.53 on Tuesday. The company has a current ratio of 3.21, a quick ratio of 3.21 and a debt-to-equity ratio of 0.17. The firm has a market cap of $1.52 billion, a PE ratio of 238.31, a P/E/G ratio of 1.71 and a beta of 1.60. Integral Ad Science has a 1-year low of $9.10 and a 1-year high of $20.88. The firm has a fifty day simple moving average of $11.69 and a two-hundred day simple moving average of $13.10.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $134.30 million during the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. Integral Ad Science’s revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.07 EPS. On average, equities analysts anticipate that Integral Ad Science will post 0.16 EPS for the current year.

Insider Activity

In other news, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $10.24, for a total transaction of $32,532.48. Following the completion of the transaction, the chief accounting officer now owns 120,195 shares in the company, valued at $1,230,796.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the transaction, the chief accounting officer now owns 120,195 shares in the company, valued at $1,230,796.80. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Lisa Utzschneider sold 30,407 shares of Integral Ad Science stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $305,590.35. Following the completion of the transaction, the chief executive officer now owns 188,678 shares of the company’s stock, valued at approximately $1,896,213.90. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock worth $876,562 over the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in IAS. Wellington Management Group LLP lifted its stake in Integral Ad Science by 15,557.5% in the first quarter. Wellington Management Group LLP now owns 3,152,174 shares of the company’s stock worth $43,500,000 after purchasing an additional 3,132,042 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Integral Ad Science by 605.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after purchasing an additional 2,351,414 shares during the last quarter. Vanguard Group Inc. lifted its stake in Integral Ad Science by 77.2% in the third quarter. Vanguard Group Inc. now owns 4,752,765 shares of the company’s stock worth $34,409,000 after purchasing an additional 2,070,907 shares during the last quarter. abrdn plc bought a new stake in Integral Ad Science in the fourth quarter worth about $25,285,000. Finally, Alliancebernstein L.P. lifted its stake in Integral Ad Science by 1,825.9% in the second quarter. Alliancebernstein L.P. now owns 943,681 shares of the company’s stock worth $16,967,000 after purchasing an additional 894,681 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.